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DiGeorge syndrome is characterised by craniofacial, cardio-
vascular and thymic and parathyroid defects resulting from a
heterozygous 3Mb deletion of chromosome 22q11 in most
patients. Haploinsufficiency of the TBX1 transcription factor is
considered to be the major underlying cause of this syndrome.
Heterozygous mouse models in which a region of MMU16
homologous to HSA22q11 is deleted (Df1) and Tbx1+/− mice
exhibit aortic arch, thymic and parathyroid defects; Tbx1−/−mice
display more severe defects of pharyngeal development. In order
to more clearly define cell autonomous effects of Tbx1 and
circumvent problems associated with tissue loss, we have
developed a novel method of comparing Tbx1 cells. The Tbx1
null allele was generated by knocking in a lacZ reporter gene into
exon 5. Using a fluorescent lacZ substrate, we have isolated
specific Tbx1 cells by FACS and compared the expression profile
of Df1/Tbx1lacZ cells to Tbx1+/lacZ cells by microarray. Down-
regulation of hemizygous Df1 genes confirmed the sensitivity of
the microarray experiment and novel potential transcriptional
targets of Tbx1 have been identified including Nkx2.6, Dab2 and
Hes1, a downstream effector of Notch signalling. Analysis of
Hes1 mouse mutants has led to the characterisation of
DiGeorge-like craniofacial, heart and glandular defects. The
genetic interaction between Hes1 and Tbx1 is currently being
investigated by crossing transgenic mouse mutants and conduct-
ing morpholino knockdown studies in zebrafish.
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CHARGE syndrome is a multiple malformation syndrome,
with characteristic anomalies including inner and outer ear
defects and cardiovascular malformations. The CHD7 gene on
chromosome 8q12.1 was recently identified as a candidate gene
and mutations are found in approximately 60% of patients. We
show that insertion of a genetrap cassette within the murine
Chd7 gene results in a mouse model of the syndrome with a
heart phenotype consistent with that observed in the human
condition. We have analysed the expression of the Chd7 gene
throughout embryonic development. Homozygous embryos do
not survive beyond 10.5 dpc. In heterozygous embryos early
growth and remodelling defects in the pharyngeal arch arteries
are detected explaining the later complex heart phenotype
consisting of rearrangements in the aortic arch and great vessels.
The heart phenotype overlaps with that seen in DiGeorge
syndrome, another congenital disease where many of the
associated defects are due to abnormal patterning of the
pharyngeal arches as shown in the Tbx1 mouse model.
Examination of Chd7+/−/Tbx1/+/− trans-heterozygous embryos
reveals an increased penetrance of anomalies resulting from
defective pharyngeal arch development, suggesting an epistatic
interaction between the two genes in this region. We also
demonstrate that Wnt1 driven restoration of Chd7 expression in
neural crest cells in an otherwise heterozygous embryo does not
rescue the arch artery defects, contrary to hypotheses proposing
the syndrome is due to irregularities in this population of cells.
doi:10.1016/j.ydbio.2007.03.137
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